See All Slides - tctmd.com

Slides

Presentation TCT 2013

Appropriateness Use Criteria Recommendations for Multivessel and Left Main Disease

Presenter: Gregory Dehmer

October 29, 2013

Presentation TCT 2013

DES Thrombosis: Evaluation and Treatment Options

Presenter: Anthony Gershlick

October 28, 2013

Presentation TCT 2013

Failure Due to Metallic Cage Jail: How Much Does Impaired Vasoreactivity, Conformability, Compliance Mismatch and Other Mechanisms Contribute to Restenosis and Stent Thrombosis?

Presenter: Patrick Serruys

October 28, 2013

Presentation TCT 2013

TCT-131. Use Of A Novel Echo-fluoroscopy Overlay System For Percutaneous Mitral Valve Intervention

Presenter: Sameer Gafoor

October 28, 2013

Presentation TCT 2013

Commercial Experience with the MitraClip in Degenerative MR in Europe

Presenter: Ralph von Bardeleben

October 28, 2013

Presentation TCT 2013

Similarities and Essential Differences in the US and EU Valve Guidelines for Management of Mitral Regurgitation

Presenter: Alec Vahanian

October 28, 2013

Presentation TCT 2013

Risk Stratification and When to Cath

Presenter: Kevin Beatt

October 28, 2013

Presentation TCT 2013

No! Still Not Ready for Prime Time

Presenter: David Adams

October 28, 2013

Presentation TCT 2013

PCI and CABG: Do We Really Need Another Trial?

Presenter: A. Pieter Kappetein

October 29, 2013

Presentation TCT 2013

SORT-OUT VI: A Prospective, Randomized, All-Comers Trial of Biodegradable Polymer-Coated Biolimus-Eluting Stents vs. Biocompatible Polymer-Coated Zotarolimus-Eluting Coronary...

Presenter: Bent Raungaard

October 29, 2013

Advertisement

Slides

Appropriateness Use Criteria Recommendations for Multivessel and Left Main Disease

DES Thrombosis: Evaluation and Treatment Options

Failure Due to Metallic Cage Jail: How Much Does Impaired Vasoreactivity, Conformability, Compliance Mismatch and Other Mechanisms Contribute to Restenosis and Stent Thrombosis?

TCT-131. Use Of A Novel Echo-fluoroscopy Overlay System For Percutaneous Mitral Valve Intervention

Commercial Experience with the MitraClip in Degenerative MR in Europe

Similarities and Essential Differences in the US and EU Valve Guidelines for Management of Mitral Regurgitation

Risk Stratification and When to Cath

No! Still Not Ready for Prime Time

PCI and CABG: Do We Really Need Another Trial?

SORT-OUT VI: A Prospective, Randomized, All-Comers Trial of Biodegradable Polymer-Coated Biolimus-Eluting Stents vs. Biocompatible Polymer-Coated Zotarolimus-Eluting Coronary...

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content